Crinetics Pharmaceuticals Inc’s recent filing unveils that its Officer DANA J PIZZUTI acquired Company’s shares for reported $0.78 million on Jan 03 ’25. In the deal valued at $52.09 per share,15,000 shares were bought.
Then, Struthers Richard Scott sold 10,000 shares, generating $575,700 in total proceeds. Upon selling the shares at $57.57, the President & CEO now owns 100,000 shares.
Before that, Struthers Richard Scott bought 10,000 shares. Crinetics Pharmaceuticals Inc shares valued at $572,700 were divested by the Officer at a price of $57.27 per share.
Citigroup initiated its Crinetics Pharmaceuticals Inc [CRNX] rating to a Buy in a research note published on March 06, 2024; the price target was $68. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who began to cover the stock in mid January with a ‘”an Overweight”‘ rating. Jefferies began covering CRNX with “Hold” recommendation on December 21, 2023.
Price Performance Review of CRNX
On Friday, Crinetics Pharmaceuticals Inc [NASDAQ:CRNX] saw its stock jump 3.10% to $53.15. Over the last five days, the stock has lost -1.43%. Crinetics Pharmaceuticals Inc shares have risen nearly 3.95% since the year began. Nevertheless, the stocks have risen 52.03% over the past one year. While a 52-week high of $62.53 was reached on 01/03/25, a 52-week low of $33.67 was recorded on 01/02/25. SMA at 50 days reached $56.17, while 200 days put it at $51.04.
Levels Of Support And Resistance For CRNX Stock
The 24-hour chart illustrates a support level at 51.98, which if violated will result in even more drops to 50.82. On the upside, there is a resistance level at 53.93. A further resistance level may holdings at 54.72. The Relative Strength Index (RSI) on the 14-day chart is 45.95, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.08, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 55.41%. Stochastics %K at 21.02% indicates the stock is a holding.
How much short interest is there in Crinetics Pharmaceuticals Inc?
A steep rise in short interest was recorded in Crinetics Pharmaceuticals Inc stocks on 2024-12-13, dropping by -0.25 million shares to a total of 6.25 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 6.5 million shares. There was a decline of -3.99%, which implies that there is a negative sentiment for the stock.
